In conclusion, we have demonstrated the critical importance of controlling the TLK1 > MK5 axis for reducing PCa metastatic spread, perhaps offering a novel point of attack to combat this incurable stage of the disease. The gene discussed is MAPKAPK5; the disease is posterior cortical atrophy.